ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2021 American Transplant Congress

June 4-9, 2021

ATC 2021 Virtual Connect is an all-new, completely enhanced virtual meeting experience. The ATC program is built in Eastern Time Zone.

View by Title View Sessions View Topics
View by Date
Jump to:  View All • a b c [d] e f g h i j k l m n o p q r s t u v w x y z
  • DAP12 Promotes Liver DC Tolerogenicity by Negative Regulation of the CGAS-STING-IFN I Pathway

    Y. Zheng1, J. Long2, N. Ryosuke1, L. Peng3, F. Peng3, A. Thomson1

  • Days of Delayed Graft Function and Its Impact on Graft Outcomes in Deceased Donor Kidney Transplant

    P. Budhiraja1, R. J. Butterfield2, S. S. Misra1, K. S. Reddy3, L. Kodali1, H. A. Khamash1, S. Nair1, G. K. Mour1, H. A. Chakkera1, C. C. Jadlowiec3, H. Janna1, R. L. Heilman1

  • DCD Heart Donation: Impact on Organ Yield

    K. Gauntt, B. Carrico, D. Klassen

  • Dd-cfdna Can Guide Safe Reintroduction of Immunosuppression in Kidney Transplant Recipients with Covid-19

    J. Miles1, J. Leonard2, V. Tatapudi2, M. Fei1, R. Montgomery2, N. M. Ali2

  • De Novo Atypical Hemolytic Uremic Syndrome (aHUS) in Kidney Transplant Recipients from the Same Donor: Possible Role of Two Genetic Hits

    C. Crane1, J. Sherbotie2, S. Anand3

  • De Novo Donor Specific Antibodies After Heart Transplantation in Fontan Patients with Protein Losing Enteropathy

    D. A. Magnetta1, V. Hoch2, D. Pinelli3, M. Monge4, E. Pahl1, P. T. Thrush1

  • De Novo Hepatitis B Infection Following Liver Transplant with Hepatitis B Core Antibody Positive Graft

    L. J. Myhre1, K. D. Watt2, B. A. Aqel3

  • De Novo Membranous Nephropathy Associated with Antibody-mediated Rejection in Renal Transplant Recipients

    M. V. Sousa1, L. G. Fernandes2, L. L. de Freitas3, R. L. Zollner2, M. Mazzali1

  • De-novo Use Comparison Between Extended-release Once-daily Tacrolimus (Envarsus Xr®) and Immediate-release Twice-daily Tacrolimus (Prograf®) – A Single Center’s Experience

    N. Singh1, T. Le1, M. S. Naseer1, S. Asmil1, A. Palermini1, A. Qamar1, R. Chand1, S. Tandukar1, D. Aultman2, H. Shokouh-Amiri2, G. Zibari2

  • Death Among Living Liver Donors- Are We Overestimating the Risk?

    H. J. Braun, A. M. Shui, N. L. Ascher, J. P. Roberts

  • Death and Loss to Follow-up in Pediatric Liver Transplant Recipients Transferred to Adult Care: Who is at Risk?

    J. P. Stevens1, S. Gillespie1, M. Katz1, L. Hall2, V. Kolachala1, R. Ford3, N. A. Gupta1

  • Deceased Donor Transplantation Across Positive Flow Crossmatch – A Single Center Experience

    M. Campara, A. Lichvar, J. Benken, S. Patel, C. Muran, D. Pierce, I. Tang, P. Di Cocco, J. Almario Alvarez, M. Spaggiari, E. Benedetti, I. Tzvetanov

  • Decreased Pca and Regional Anesthesia Requirements Following Robotic Donor Nephrectomy

    J. C. Alonso-Escalante, L. Machado, K. R. Tabar, R. P. Tindall, N. Thai, T. Uemura

  • Deep Learning Based Automatic Liver Volume Estimation and Segmentation via U-net Convolutional Neural Network

    B. Marlatt1, R. Pettit2, J. Havelka1, S. J. Corr3, A. Rana2

  • Defining the Characteristics and Graft Outcomes of Kidney Transplant Recipients with Elevated Plasma Oxalate Level Not Due to Primary Hyperoxaluria

    D. Khan, N. Zhang, M. Keddis

  • Degree of T Cell Infiltration Predicts Treatment Response in Pediatric Liver Late Acute Cellular Rejection

    M. Rogers, G. Begum, Q. Sun, A. Peters

  • Delay in Pediatric Kidney Transplantation Due to Infection: A Single Center Study

    T. A. Heald-Sargent1, S. Manz2, P. Verghese3

  • Delayed Graft Function in Pediatric Living Donor Kidney Transplantation

    M. MacConmara, J. Shah, L. de Gregorio, D. Desai, P. Vagefi, C. S. Hwang

  • Delayed Valganciclovir Initiation and the Incidence of Cytomegalovirus Infection in Liver Transplant Recipients

    S. Shaikh, P. Kawewat-Ho, Y. Genyk, L. Sher, J. Kahn, L. Rivera

  • Depressive Symptoms and Listing for Kidney Transplantation

    X. Chen, N. Chu, P. Sharma Basyal, W. Vihokrut, D. Crews, D. Brennan, S. Andrews, T. Vannorsdall, D. Segev, M. McAdams DeMarco

  • Desensitization Using Clazakizumab® (anti-il-6) in Highly-hla Sensitized Patients Awaiting Kidney Transplant (nct03380962)

    A. A. Vo1, N. Ammerman1, E. Huang1, M. Toyoda2, S. Ge2, A. Peng1, R. Najjar1, S. Sethi1, S. Williamson1, C. Myers1, K. Lim1, M. Gillespie1, S. Jordan1

  • Desensitization Using Costimulatory Blockade and Bortezomib to Prevent DSA Formation and Rejection in Reconstructive Transplantation

    B. Oh1, F. Messner2, Y. Guo1, G. Brandacher1

  • Desensitization with Plasmapheresis and IV Immunoglobulin is Safe and Effective in Pra Positive Kidney Transplant Recipient Candidates in Covid-19 Pandemic Period

    B. Sayin1, A. Akdur2, E. Karakaya2, U. Musabak3, T. Colak1, M. Haberal2

  • Detection of Rejection in Kidney Transplant Patients Using an Algorithm That Combines Donor Fraction and Absolute Donor-derived Cell-free DNA

    S. Bunnapradist1, E. Ahmed2, M. Maninder2, Z. P. Demko2, P. R. Billings2, H. Tabriziani2, P. Gauthier3

  • Detection of SARS-CoV-2 Specific Functional T Cells Using a Seven Color Flow Cytometry Assay

    L. Flebbe-Rehwaldt, J. Hayden, K. Mickey, S. Manley, S. Kleiboeker

  • Determining Endpoint Criteria in Ex Vivo Normothermic Limb Perfusion (EVNLP)

    S. K. Pandey1, A. Meyers1, P. Sadeghi1, V. Kopparthy1, T. Xia1, H. Brunengraber2, S. Dasarathy3, A. Rampazzo1, B. Bassiri Gharb1

  • Detrusor Reinforced Lich-Gregoir Ureteroneocystostomy for Kidney Transplants Recipients: Comparative Analysis of the First 100 Cases

    R. H. Astolfi, J. Medina-Pestana, H. Tedesco Silva Junior, W. Aguiar

  • Developing a Robot-assisted Donor Nephrectomy Program in a High Volume Laparoscopic Living Donor Nephrectomy Program

    S. S. Lee, N. Vachharajani, M. Pfeiffer, S. Matson, M. Scherer, M. Doyle, J. Wellen, Y. Lin, T. Rice, J. Yu, A. Khan

  • Developing and Validation of a Liver Transplantation Donation After Cardiac Death Risk Index Using the UNOS Database

    L. Chau, K. Delvecchio, A. Mohamed, M. Lu, T. Kitajima, S. Yedulla, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud, S. Nagai

  • Development and Durability of Sars-cov-2 Antibodies Among Solid Organ Transplant Recipients

    B. Boyarsky, M. Ou, R. Greenberg, M. Krach, R. Wang, T. P. Chiang, W. Werbel, R. Avery, W. Clarke, A. Tobian, A. Massie, D. Segev, J. Garonzik-Wang

  • Development and Validation of a Nomogram for Remnant Kidney Function After Living-donor Donation

    M. Dou, P. Tian, B. Zheng, G. Deng, Y. Shi, C. Ding

  • Development and Validation of a Novel Peripheral Blood Based Gene Signature for Acute Rejection Following Renal Transplantation

    D. Zhang, Y. Wang, X. Hu

  • Development Following Pediatric Kidney Transplantation

    L. Pape, J. Prüfe

  • Development of a Lateral Flow Assay Detecting CXCL9 within Antibody Mediated and Acute T Cell Mediated Rejections After Kidney Transplantation

    L. K. Seiler1, R. Jonczyk1, P. Lindner1, L. Phung1, C. Falk2, C. Blume1

  • Development of a Question Prompt Sheet for Upper Extremity Vascularized Composite Allotransplantation

    J. Gacki-Smith1, B. Kuramitsu1, A. Ferzola2, K. Vanterpool2, C. Kunkle3, M. Hewitt3, A. Schultheis3, T. Riggleman3, J. Taylor3, C. Cooney2, M. Levan2, S. Tintle3, G. Brandacher2, E. Gordon1

  • Development of a Rat Model of Antibody-Mediated Rejection After Liver Transplantation

    T. Tajima, K. Hata, J. Kusakabe, H. Miyauchi, S. Uemoto

  • Development of De Novo Antibody in Renal Transplant Recipients with BK Viremia Managed with Immunosuppression Reduction

    R. Hod Dvorai1, R. Lee2, P. Muluhngwi2, M. Raijmakers3, A. Shetty2, A. Tambur2, M. Ison2

  • Development of De-novo Malignancies After Kidney and/or Pancreas Transplantation in Diabetic Patients

    A. Gruessner, S. Saggi, J. Renz, R. Gruessner

  • Development of Diagnosis Method of Acute Graft Rejection After Kidney Transplantation Using Metabolome Analysis by Liquid Biopsy Approach

    H. Iwamoto1, M. Sugimoto2, O. Konno1, I. Akashi3, M. Okihara1, Y. Kihara1, T. Ueno1

  • Development of Novel Multivariable Logistic Regression Model for Predicting Acute Kidney Injury After Liver Transplantation

    H. Chen, Y. Nie, Q. Zhao, X. He

  • Developmental Characteristics and Haemodynamics After Pediatric Donor to Adult Recipients in Liver Transplantation

    M. Chen, L. Xiaohong, H. Xitao, C. Zhitao, J. W.

  • Dialysis Staff-Reported Impact of the Early Covid-19 Pandemic on Kidney Transplant Referrals and Evaluations

    A. Perez1, S. Retzloff1, T. Browne2, A. Cruz3, S. Wright3, S. Pastan4, R. Patzer1

  • Dietary Intake and Mycophenolate Mofetil-related Diarrhea Following Kidney Transplantation

    G. Onyeaghala1, L. Teigen2, B. Guo2, Y. Doronin1, M. Al-Kofahi2, B. Wu2, W. Guan2, C. Staley2, S. Riad2, A. Matas2, R. Remmel2, W. Oetting2, C. Dorr1, P. Jacobson2, A. Israni1

  • Dietary Intake of Calories and Protein in the Acute Phase Following Kidney Transplant: Opportunities for Improvement

    L. Teigen1, G. Onyeaghala1, Y. Doronin2, B. Guo1, B. Wu1, J. Abrahante1, D. Schladt1, W. Guan1, C. Staley1, M. Al-Kofahi1, S. Riad1, A. Matas1, R. Remmel1, W. Oetting1, C. Dorr1, P. Jacobson1, A. Israni1

  • Different Levels of GFR of Retained Kidney on the Long-term Safety of the Donors in Living-related Renal Transplantation

    M. Dou, P. Tian, B. Zheng, G. Deng, Y. Shi, C. Ding

  • Diffuse Calcification Pattern in Chronic Pancreatitis Has Two Aspects in Total Pancreatectomy with Islet Autotransplantation: Bad Sign for Islet Graft Function and Good Sign for Pain Relief

    Y. Liu, K. Kumano, J. Mattke, C. Darden, S. Vasu, M. Lawrence, G. Testa, A. Gupta, E. Beecherl, N. Onaca, B. Naziruddin

  • Digital Spatial Mrna Profiling Reveals Distinct Endothelial Transcripts in Dsa+ and Dsa- Endarteritis in Kidney Allografts

    K. Tomaszewski1, M. Araujo Medina1, A. Bruce1, P. Divakar2, R. Smith1, T. Kawai3, R. Colvin1, I. Rosales1

  • Discontinuation of Trimethoprim/sulfamethoxazole Prophylaxis Due to Hyperkalemia in Kidney Transplant Recipients

    D. Pett1, G. Malat2, C. Domenico1, R. Samudralwar1, A. Forte1, D. Sawinski2, J. Hu1, B. Steiner1, J. Rashid1, J. Trofe-Clark2

  • Disparities in Access to Listing in Rural Populations Post-KAS Implementation

    S. H. Nguyen1, R. R. Redfield2, N. Neidlinger1, D. P. Foley1, D. B. Kaufman1, J. T. Adler3

  • Disparities in HLA Representation by Single Antigen Reagents in Different Ethnic Populations

    J. C. Quon1, J. Menteer2, N. Fotiadis2, R. M. Lestz2, L. A. Baxter-Lowe2

  • Disparities in Living Donor Follow-up During the COVID-19 Emergency Suspension of OPTN Follow-up Reporting Requirements

    S. E. Booker, A. Henderson, L. A. Cartwright, S. Taranto, D. Klassen, J. L. Wainright

  • Dissecting the Intrarenal Immune Response to Viral Infected Cells in Pediatric BK Virus-associated Nephropathy (BKVAN)

    D. M. Okamura1, S. W. Jackson1, V. R. Dharnidharka2, J. M. Smith1

  • Distal Allograft Pancreatectomy for Graft Salvage After Pancreas Transplantation

    D. Soma, T. Nikumbh, A. J. Lutz, J. A. Powelson, J. A. Fridell

  • Distinct Phenotype and Function of Antibody-suppressor Cxcr5+Cd8+ T Cells

    J. Zimmerer, J. Han, M. Hart, S. Chaudhari, C. Peterson, G. Bumgardner

  • Dna-pkcs Regulation of the Allogeneic Immune Response

    L. Burdine, M. Burdine, Z. Waldrip, D. Harrison

  • Do Pretransplant C-peptide Levels Influence Outcomes in Simultaneous Pancreas-Kidney Transplantation? A Matched Case-Control Study

    K. B. Gurung, V. Gurram, J. Rogers, A. C. Farney, G. Orlando, C. L. Jay, A. Reeves-Daniel, A. Mena-Gutierrez, N. Sakhovskaya, W. Doares, S. Kaczmorski, M. D. Gautreaux, R. J. Stratta

  • Does High-Risk CMV Discordance Affect Elderly Kidney Transplant Recipient Survival? A Multivariable Analysis

    A. Dinesh1, S. Jackson2, S. Riad3, T. L. Pruett1

  • Does the NSQIP-Transplant Experience Demonstrate That Obese Kidney Transplant Recipients are Still at Increased Risk for Surgical Site Infections?

    H. C. Yaffe1, A. K. Belli1, J. R. Parekh2, D. L. Sudan3, N. Elias4, K. D. Conzen5, D. P. Foley6, R. Hirose7, S. M. Greenstein1

  • Does the Timing of Subclinical Acute Rejection After Kidney Transplant Matter?

    P. Portocarrero1, S. Park2, K. Guo3, L. Zhao3, J. Friedewald2

  • Donation After Cardiac Death (DCD) Agonal Phase Physiology is Associated with Post-transplant Kidney Graft Outcomes

    A. Kayastha1, K. C. Eddinger2, E. M. Sonnenberg2, N. Mahmud2, D. E. Schaubel1, P. L. Abt2

  • Donation After Circulatory Death Kidney Transplantation Has Equal Long-Term Graft and Patient Survival as Donation After Brain Death: A Systematic Review and Meta-Analysis

    E. Rijkse1, S. Ceuppens1, H. Qi2, J. N. IJzermans1, D. A. Hesselink3, R. C. Minnee1

  • Donor CPR and Solid Organ Transplantation

    E. Larsen1, K. Cardoza2, K. Robichaux3, A. Kumar1, V. Bowers4, J. Buggs4

  • Donor Derived Cell Free DNA Identifies Rejection in Simultaneous Pancreas Kidney Transplant Recipients

    M. Williams1, S. Ghosh2, L. L. Jenkins2, M. Hertl1, S. Saltzberg3, V. Peev3, E. Chan1, E. Hollinger1, E. Schadde1, O. Olaitan1

  • Donor Derived Cell Free Dna: Teasing Out the Optimal Threshold for Antibody Mediated Rejection

    M. Mattu1, H. Murad1, M. Merzkani1, A. Malone1, R. Delos Santos1, M. Wang2, B. Wang2, S. Chang2, T. Alhamad1

  • Donor Derived Cell-Free DNA (dd-cfDNA) in Pancreas Transplant Recipients

    S. Riad1, H. Sarumi2, R. Kandaswamy3

  • Donor Derived Cell-free DNA Kinetics Early After Kidney Transplant in Patients with Delayed Graft Function Who Received Kidneys from Donation After Cardiac Death Donors

    R. Gumber, M. Abuzeineh, C. Mejia, D. Brennan, F. Naqvi

  • Donor Derived Cell-free-dna (dd-cfdna) as a Surrogate Marker for Kidney Biopsy- Indiana University Transplant Nephrology Experience

    S. Valavoor1, A. Sharfuddin2, G. William3, M. Yaqub1, D. Mishler1, O. Adebiyi2

  • Donor Derived Transmissions 2019: Analysis of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC)

    L. Danziger-Isakov1, M. G. Michaels1, A. Agarwal1, S. Aslam1, K. Dunn1, J. Goldman1, D. Levine1, C. Marboe1, G. Marklin1, S. Pouch1, M. Rana1, R. Razonable1, H. L. Stevenson1, H. S. Te1, A. Woolley1, E. Ward2, C. Jett2, L. Cartwright2, R. La Hoz1

  • Donor Factors Associated with In-field Decline of Heart Allografts

    L. Piechura, F. Yazdchi, M. Harloff, H. Shim, M. Keshk, A. Coppolino, III, D. Rinewalt, H. Mallidi

  • Donor Kidney-Resident Macrophages Promote Allograft Inflammation and CD8 T Cell Response Post-Transplantation

    A. Dangi1, S. Yu2, I. Husain1, R. Geesala1, X. Luo1

  • Donor Lymphocytes in Peripheral Blood of Patients After Lung Transplantation Comprise High Frequencies of Killer Cell Immunoglobulin-like Receptor-positive T and NK Cell Subsets

    J. F. Kühne1, A. Hitz1, K. A. Bläsing1, B. Wiegmann2, R. Bellmàs Sanz1, F. Ius2, A. Haverich2, G. Warnecke2, C. S. Falk1

  • Donor Mhc-independent Islet Rejection in Autoimmune Diabetes: Implications for Stem Cell Therapy

    R. G. Gill1, M. Coulombe2, K. S. Beard1, A. L. Burrack3

  • Donor Service Area Characteristics Impacting Liver and Kidney Deceased Donor Population

    C. O. Warren, A. Zarrinpar

  • Donor T and NK Cells with a Special Tissue-Resident Memory Phenotype Migrate Into the Periphery of Lung Transplant Recipients – A Potential Feature for Tolerance Development

    L. M. Ruhl1, R. Bellmàs Sanz1, A. Hitz1, B. Wiegmann2, K. A. Bläsing1, W. Sommer2, F. Ius2, J. F. Kühne1, A. Knöfel2, L. M. Horn1, I. Tudorache2, A. Haverich2, D. Jonigk3, G. Warnecke2, C. S. Falk1

  • Donor-Derived Cell-Free DNA as a Surrogate Marker for “Allograft Quiescence” After Kidney Transplantation

    J. S. Bromberg1, L. Bu2, G. Gupta3, I. Moinuddin3, S. Anand4, A. Pai5, T. Alhamad6, V. Bowers7, S. Ghosh8, W. Tian8, E. Stites9

  • Donor-Derived Cell-Free DNA Can Differentiate Rejection versus Other Causes of Pancreas Transplant Dysfunction

    N. Ali1, J. Miles2, Z. Stewart Lewis1

  • Donor-derived Cell-free DNA Distinguishes Acute Rejection from Other Causes of Graft Injury in Liver Transplant Recipients

    J. Levitsky1, M. Miller2, R. Sinha2, E. Bixler2, A. Al-Turck2, J. Weems2, M. Altrich2, S. Kleiboeker2, M. Abecassis3

  • Donor-derived Cell-free DNA in Upper Extremity Vascular Composite Allograft Recipients

    R. Kalsi1, M. Abuzeineh2, J. Littleton1, J. T. Shores1, D. S. Cooney1, C. Cooney1, R. J. Redett1, G. Brandacher1, D. C. Brennan2

  • Donor-Derived Cell-Free DNA Levels Risk-Stratify Polyoma BK Viremia and Associated Clinical Events After Kidney Transplantation – Preliminary Results from ADMIRAL Study

    A. Pai1, L. Bu2, J. S. Bromberg3, G. Gupta4, I. Moinuddin4, T. Alhamad5, V. Bowers6, S. Ghosh7, W. Tian7, E. Stites8, S. Anand9

  • Donor-Derived Cell-Free DNA Performance Characteristics are Similar for Repeat and Primary Kidney Transplant Recipients

    V. R. Peddi1, S. Akkina2, S. C. Jordan3, W. Tian4, Y. Qazi5

  • Donor-Derived Tuberculosis in Lung Transplant Recipients, a Single Center Experience

    M. Robbins, D. Kabbani, C. Cervera, C. O'Neil, R. Cooper, K. Halloran, S. Grocholski, K. Doucette

  • Donor-Recipient BSA Matching is Prognostically Significant in Solitary and En-bloc Kidney Transplantation from Pediatric Circulatory Death Donors

    C. J. Little, A. A. Dick, J. D. Perkins, J. D. Reyes

  • Donor-specific Anti-HLA Alloantibody in Kidney Transplant Recipients with COVID-19 Exhibit a Different Immunoglobulin Class and Subclass Profile When Compared to Anti-SARS-CoV-2 Antibodies

    A. Girnita1, L. Wang1, M. Fernandez-Vina1, E. Woodle2, P. Ahearn1, T. Yalamarti1, M. Menon3, Y. Azzi4, M. Melcher1, R. Bray5, H. Gebel5, E. Akalin4, P. Cravedi3, J. S. Maltzman1

  • Donor-specific Regulatory B Cells Prolong Skin Graft Survival by Preventing the Proliferation of Donor-specific CD4 Helper but Not of CD8 Effector T Cells

    G. Huai1, K. Lee2, K. Deng2, Q. Fu1, C. G. Rickert2, S. Deng1, C. LeGuern2, J. F. Markmann2

  • Dosing Weight of Rabbit Antithymocyte Globulin and Outcomes Among Kidney Transplant Patients Treated for Rejection

    C. Patton, K. Cunningham, C. D'Agostino, A. Novak, M. Kapugi, K. Lang, C. Kane

  • Double Negative T Cells Mediate Cd39-Dependent Protection in Hepatic Ischemia and Reperfusion Injury

    H. Jin, M. Li, C. Zhang, G. Sun, D. Zhang

  • Drivers of Graft Failure in Pediatric Kidney Transplant Change Over Time

    E. Benz1, D. Schaubel2, S. Amaral1

  • Drones and Airplanes: Modeling the Potentially Deleterious Effects of Transportation on Shipped Organs

    Y. S. Lee, J. S. Bromberg, J. R. Scalea

  • DSA Causes Mild Molecular ABMR-like Changes in Many Biopsies Not Diagnosed as Rejection

    P. F. Halloran1, K. S. Madill-Thomsen1, &. the INTERCOMEX Study Group2

  • DSA is Associated with Molecular Changes in Many Hearts with Minor Abnormalities but Not Diagnosed as Antibody-Mediated Rejection

    P. Halloran1, K. S. Madill-Thomsen1, &. the INTERHEART Study Group2

  • Dual Lactate Clearance in the Liver Viability Assessment During Normothermic Machine Perfusion

    M. Xu1, F. Zhou1, O. Ahmed1, J. Shin1, Y. Zhu1, G. Upadhya1, K. Byrnes2, B. Wong1, J. Kim1, Y. Lin1, W. Chapman1

  • Dual Liver and Kidney Donors, What Makes Them Decide to Do It?

    H. Al Harakeh, B. Emmanuel, C. Hughes, A. Tevar, J. Steel, A. F. DiMartini, S. Ganesh, A. Humar

  • Dual-Agent Induction Therapy for Pancreas Transplantation: A Single-center Experience

    E. C. Liu1, J. H. Lee1, R. Craig-Schapiro2, M. Aull2, S. Sultan2

  • Duration and Magnitude of BK Viremia Do Not Predict Outcome in Patients After Kidney Transplantation

    E. A. Farkash1, J. T. Rajagopal2, M. Vincent2, M. D. Doshi3

  • Dynamic Forecasting of Patient-Specific Kidney Transplant Function with a Sequence-to-Sequence Deep-Learning Model

    E. Van Loon1, W. Zhang2, A. Van Craenenbroeck1, B. De Moor2, M. Naesens1

  • Dynamic Reconstitution of Recipient Resident Memory T Cell Repertoire After Human Intestinal Transplantation

    W. Jiao, M. Martinez, J. Zuber, A. Obradovic, R. Jones, E. Waffarn, Z. Wang, A. Gorur, K. Rogers, T. Kato, Y. Shen, J. Fu, M. Sykes

  • Dynamics of IgG Subclass as a Mechanism of Desensitization Using Rituximab for Presensitized Patients Undergoing Living Related Liver Transplantation

    H. Egawa1, K. Ide2, T. Ishizuka3, H. Ohdan4, Y. Kotera1, T. Kato1, A. Ohmori1, Y. Hirata1, G. Shibuya1, S. Yamashita1, S. Ariizumi1

  • Dysregulation of Immune Cell Glycolysis and Oxidative Phosphorylation Correlates with Development of Pre-liver Transplant Immune Dysfunction and Post-transplant Mortality

    G. Panayotova1, L. Jin1, A. Lemenze1, S. Simonishvili1, Y. Qin1, L. Minze2, G. Dikdan1, F. Paterno1, X. C. Li2, M. Ghobrial2, J. V. Guarrera1, K. E. Lunsford1

Jump to:  View All • a b c [d] e f g h i j k l m n o p q r s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences